Cargando…
In Vitro Comparison of Lymphangiogenic Potential of Hypoxia Preconditioned Serum (HPS) and Platelet-Rich Plasma (PRP)
Strategies for therapeutic lymphangiogenesis are gradually directed toward the use of growth factor preparations. In particular, blood-derived growth factor products, including Hypoxia Preconditioned Serum (HPS) and Platelet-rich Plasma (PRP), are both clinically employed for accelerating tissue rep...
Autores principales: | Jiang, Jun, Cong, Xiaobin, Alageel, Sarah, Dornseifer, Ulf, Schilling, Arndt F., Hadjipanayi, Ektoras, Machens, Hans-Günther, Moog, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916704/ https://www.ncbi.nlm.nih.gov/pubmed/36768283 http://dx.doi.org/10.3390/ijms24031961 |
Ejemplares similares
-
Hypoxia Preconditioned Serum (HPS) Promotes Osteoblast Proliferation, Migration and Matrix Deposition
por: Jiang, Jun, et al.
Publicado: (2022) -
Effect of Hypoxia Preconditioned Secretomes on Lymphangiogenic and Angiogenic Sprouting: An in Vitro Analysis
por: Moog, Philipp, et al.
Publicado: (2020) -
Hypoxia Preconditioned Serum (HPS)-Hydrogel Can Accelerate Dermal Wound Healing in Mice—An In Vivo Pilot Study
por: Jiang, Jun, et al.
Publicado: (2022) -
Comparative Evaluation of the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes and Platelet-Rich Plasma: An In Vitro Analysis
por: Moog, Philipp, et al.
Publicado: (2020) -
Hypoxia Preconditioned Serum (HPS) Promotes Proliferation and Chondrogenic Phenotype of Chondrocytes In Vitro
por: Jiang, Jun, et al.
Publicado: (2023)